Permanently Discontinued

CEFZIL TABLETS - 250MG

BRISTOL-MYERS SQUIBB CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CEFZIL TABLETS - 250MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CEFZIL TABLETS - 250MG has been permanently discontinued (last updated July 1, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CEFZIL TABLETS - 250MG not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength250MG

Last updated2017-07-01

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SPC-CEFPROZIL

SUN PHARMA CANADA INC

250MG · DIN 02293528

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AVA-CEFPROZIL

AVANSTRA INC

250MG · DIN 02362848

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

SANDOZ CEFPROZIL

SANDOZ CANADA INCORPORATED

250MG · DIN 02303434

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

CEFPROZIL TABLETS

RANBAXY PHARMACEUTICALS CANADA INC.

500MG · DIN 02332043

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

MINT-CEFPROZIL

MINT PHARMACEUTICALS INC

500MG · DIN 02317311

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-CEFPROZIL

AURO PHARMA INC

125MG · DIN 02347261

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02163659

Strength

250MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CEFPROZIL

Tier

Unrated

Last Updated

2017-07-01

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

15MG · DIN 02532573

CAMZYOS

5MG · DIN 02532557

CAMZYOS

2.5MG · DIN 02532549